Newsroom

News, publications & scientific expertise

Follow our press releases, our scientific publications on regulatory toxicology, and our upcoming events.

Featured

Articles 13 Oct 2026

Genotoxic vs non-genotoxic carcinogens: why the distinction drives your strategy

Genotoxic vs non-genotoxic carcinogens: the threshold vs non-threshold distinction, why it changes risk assessment, and how genotoxicity data drives your testing strategy.

Read the article →

Articles

Articles 29 Sep 2026

ICH S2(R1): the standard genotoxicity battery for pharmaceuticals

Articles

Articles 15 Sep 2026

Mouse lymphoma assay & TK6 (OECD 490): the mammalian gene-mutation test

All articles

Showing 12 of 63 articles

Year

Event 08 Sep 2026

GenEvolutioN at CPHI Milan 2026

Articles

Articles 01 Sep 2026

In vitro chromosomal aberration test (OECD 473): detecting clastogens

Articles 12 Août 2026

Medical device genotoxicity: what ISO 10993-3 and ISO 10993-33 require

Articles 22 Juil 2026

ICH M7 explained: assessing and controlling DNA-reactive (mutagenic) impurities

Articles 08 Juil 2026

The comet assay (OECD 489): reading DNA strand breaks, cell by cell

Event 07 Juil 2026

Rapid Micronucleus MoA: reading genotoxicity mechanisms with Telomere & Centromere FISH

Event 30 Juin 2026

New Approach Methodologies (NAMs): The Future of Regulatory Toxicology

News 14 Juin 2026

Nitrosamine Ames Test (NDSRIs) | OECD 471

Articles 25 Mai 2026

gH2AX assay: a smarter genotoxicity strategy

News 13 Mai 2026

PFAS explained: what “forever chemicals” are and why testing them matters

Strategic partnership 05 Mai 2026

GenEvolutioN joins Cosmetic Valley, the heart of France’s cosmetic industry

Aknowledgement 22 Avr 2026

Stem cells: genotoxic risks and quality controls in cell therapy development

Event 13 Avr 2026

GenEvolutioN named Gold Sponsor of TOX’26: supporting the future of predictive toxicology

Aknowledgement 23 Mar 2026

Phototoxicity: understanding the science behind light-induced toxicity

Articles 16 Mar 2026

Genotoxicity: definition, mechanisms, tests & regulatory requirements

Articles 09 Mar 2026

From crisis to confidence: lessons learned from nitrosamine recalls

Strategic partnership 05 Mar 2026

GenEvolutioN is now listed on Skinobs — the global reference platform for cosmetic testing providers

Articles 11 Fév 2026

AMES test: history, principle, and its role in modern genotoxicity screening

Event 08 Fév 2026

GenEvolutioN at SOT 2026: strengthening our scientific footprint in toxicology

Event 04 Fév 2026

GenEvolutioN at In-Cosmetics Global 2026: Meet our genotoxicology experts in Paris

Articles 01 Fév 2026

Endocrine disruptors: mechanisms of action and impact on human health

Articles 28 Jan 2026

From cosmetics to food packaging: sectors most impacted by endocrine disruptors

Strategic partnership 27 Jan 2026

AsedaSciences® and GenEvolutioN® announce Sales and Marketing Agreement to Integrate Best-in-Class Micronucleus Genotoxicity Screen into the 3RnD® Platform

Articles 16 Jan 2026

Mutagenicity concerns across industries: why one size does not fit all

Articles 08 Jan 2026

What are PFAS? Understanding these substances through scientific characterization

Articles 26 Nov 2025

From Ames to micronucleus: bridging mutagenicity and clastogenicity

Articles 25 Nov 2025

Micronucleus test: a cornerstone of genotoxicity assessment

Articles 21 Nov 2025

Enhanced Ames test: a new era in nitrosamine genotoxicity assessment

Articles 10 Nov 2025

What Is the function of the Micronucleus? Understanding the Science behind Genotoxicity

Articles 02 Nov 2025

Nitrosamine impurities in pharmaceuticals: prevention starts upstream

Articles 20 Oct 2025

GenEvolutioN at the Cosmetics Regulatory Congress 2025

Articles 20 Oct 2025

Why are Nitrosamines so difficult to detect?

Articles 30 Sep 2025

Nitrosamines: regulatory challenges and analytical solutions

Event 30 Sep 2025

GenEvolution at CPHI Frankfurt 2025: expertise in nitrosamines and impurities control

Articles 25 Sep 2025

Navigating food regulations in Europe: a complete guide

Articles 22 Sep 2025

GLP, ISO 17025, ISO 10993 : How to turn constraints into allies

Event 15 Sep 2025

GenEvolutioN at Cosmetic360 2025: Where predictive science meets responsible beauty

Articles 15 Août 2025

Ames Test: the gold standard for mutagenicity screening

Case study 08 Août 2025

From positive Ames Test to informed product safety — the GenEvolutioN difference

Event 05 Août 2025

GenEvolutioN to exhibit at IFSCC 2025: Showcasing Innovation in In Vitro Cosmetic Testing

Event 04 Août 2025

GenEvolutioN showcases advances in RSMN testing at EUROTOX 2025

Articles 01 Août 2025

What is mutagenicity? Understanding the risks & testing methods

Articles 24 Juil 2025

Genotoxicity in cosmetics: meeting regulatory and consumer expectations

Awards 10 Juil 2025

COFRAC accreditation: a mark of excellence at GenEvolutioN

Case study 04 Juil 2025

Genotoxicity testing of a poorly soluble polymer: overcoming matrix complexity (UVCB)

Articles 01 Juil 2025

From OECD guidelines to innovation: the future of genotoxicity testing

Articles 27 Juin 2025

Enhanced AMES test and genotoxicity: advancing the detection of nitrosamine impurities

Articles 22 Juin 2025

Genotoxicity: why early in vitro testing is critical for product safety

Articles 13 Juin 2025

What is genotoxic? Understanding genotoxicity and its importance in product safety

Webinar 07 Juin 2025

Analytical impurities: what you don’t control could cost you – join our expert webinar!

Articles 21 Mai 2025

Genotox laboratories: ensuring product safety with advanced genotoxicity testing

Event 14 Avr 2025

GenEvolutioN at Vitafoods Barcelona 2025: Exploring the future of nutraceutical testing

Event 11 Avr 2025

GenEvolutioN at CosmetoTEST Lyon 2025: Showcasing Next-Generation In Vitro Cosmetic Testing

Event 10 Avr 2025

In-Cosmetics Amsterdam: GenEvolutioN’s success in cosmetic innovation

Press releases 05 Mar 2025

GenEvolutioN & DRC Join Forces for Nitrosamines Risk Management in Pharmaceuticals

Event 23 Fév 2025

GenEvolutioN at SOT 2025: showcasing innovations in In Vitro Genetic Toxicology

Aknowledgement 23 Sep 2024

Improving biological dosimetry with telomere–centromere FISH

Aknowledgement 23 Avr 2024

NanoAmes: A high-precision tool for mutagenicity testing with ultra-low sample quantities

Press releases 14 Mar 2024

A new in vitro DPRA test

Aknowledgement 10 Mar 2024

Cell transformation assay with fluorescent labelling

Press releases 29 Fév 2024

A new miniaturized cell transformation assay

Aknowledgement 23 Fév 2023

Optimizing in vitro micronucleus assays

Awards 19 Mar 2019

Genotoxic vs non-genotoxic carcinogens: why the distinction drives your strategy

ICH S2(R1): the standard genotoxicity battery for pharmaceuticals

Mouse lymphoma assay & TK6 (OECD 490): the mammalian gene-mutation test

GenEvolutioN at CPHI Milan 2026

In vitro chromosomal aberration test (OECD 473): detecting clastogens

Medical device genotoxicity: what ISO 10993-3 and ISO 10993-33 require

ICH M7 explained: assessing and controlling DNA-reactive (mutagenic) impurities

The comet assay (OECD 489): reading DNA strand breaks, cell by cell

Rapid Micronucleus MoA: reading genotoxicity mechanisms with Telomere & Centromere FISH

New Approach Methodologies (NAMs): The Future of Regulatory Toxicology

Nitrosamine Ames Test (NDSRIs) | OECD 471

gH2AX assay: a smarter genotoxicity strategy

PFAS explained: what “forever chemicals” are and why testing them matters

GenEvolutioN joins Cosmetic Valley, the heart of France’s cosmetic industry

Stem cells: genotoxic risks and quality controls in cell therapy development

GenEvolutioN named Gold Sponsor of TOX’26: supporting the future of predictive toxicology

Phototoxicity: understanding the science behind light-induced toxicity

Genotoxicity: definition, mechanisms, tests & regulatory requirements

From crisis to confidence: lessons learned from nitrosamine recalls

GenEvolutioN is now listed on Skinobs — the global reference platform for cosmetic testing providers

AMES test: history, principle, and its role in modern genotoxicity screening

GenEvolutioN at SOT 2026: strengthening our scientific footprint in toxicology

GenEvolutioN at In-Cosmetics Global 2026: Meet our genotoxicology experts in Paris

Endocrine disruptors: mechanisms of action and impact on human health

From cosmetics to food packaging: sectors most impacted by endocrine disruptors

AsedaSciences® and GenEvolutioN® announce Sales and Marketing Agreement to Integrate Best-in-Class Micronucleus Genotoxicity Screen into the 3RnD® Platform

Mutagenicity concerns across industries: why one size does not fit all

What are PFAS? Understanding these substances through scientific characterization

From Ames to micronucleus: bridging mutagenicity and clastogenicity

Micronucleus test: a cornerstone of genotoxicity assessment

Enhanced Ames test: a new era in nitrosamine genotoxicity assessment

What Is the function of the Micronucleus? Understanding the Science behind Genotoxicity

Nitrosamine impurities in pharmaceuticals: prevention starts upstream

GenEvolutioN at the Cosmetics Regulatory Congress 2025

Why are Nitrosamines so difficult to detect?

Nitrosamines: regulatory challenges and analytical solutions

GenEvolution at CPHI Frankfurt 2025: expertise in nitrosamines and impurities control

Navigating food regulations in Europe: a complete guide

GLP, ISO 17025, ISO 10993 : How to turn constraints into allies

GenEvolutioN at Cosmetic360 2025: Where predictive science meets responsible beauty

Ames Test: the gold standard for mutagenicity screening

From positive Ames Test to informed product safety — the GenEvolutioN difference

GenEvolutioN to exhibit at IFSCC 2025: Showcasing Innovation in In Vitro Cosmetic Testing

GenEvolutioN showcases advances in RSMN testing at EUROTOX 2025

What is mutagenicity? Understanding the risks & testing methods

Genotoxicity in cosmetics: meeting regulatory and consumer expectations

COFRAC accreditation: a mark of excellence at GenEvolutioN

Genotoxicity testing of a poorly soluble polymer: overcoming matrix complexity (UVCB)

From OECD guidelines to innovation: the future of genotoxicity testing

Enhanced AMES test and genotoxicity: advancing the detection of nitrosamine impurities

Genotoxicity: why early in vitro testing is critical for product safety

What is genotoxic? Understanding genotoxicity and its importance in product safety

Analytical impurities: what you don’t control could cost you – join our expert webinar!

Genotox laboratories: ensuring product safety with advanced genotoxicity testing

GenEvolutioN at Vitafoods Barcelona 2025: Exploring the future of nutraceutical testing

GenEvolutioN at CosmetoTEST Lyon 2025: Showcasing Next-Generation In Vitro Cosmetic Testing

In-Cosmetics Amsterdam: GenEvolutioN’s success in cosmetic innovation

GenEvolutioN & DRC Join Forces for Nitrosamines Risk Management in Pharmaceuticals

GenEvolutioN at SOT 2025: showcasing innovations in In Vitro Genetic Toxicology

Improving biological dosimetry with telomere–centromere FISH

NanoAmes: A high-precision tool for mutagenicity testing with ultra-low sample quantities

A new in vitro DPRA test

Cell transformation assay with fluorescent labelling

A new miniaturized cell transformation assay

Optimizing in vitro micronucleus assays

GenEvolutioN: Award-Winning Entrepreneurial Spirit Recognized by GPS&O — A Legacy That Endures

Let’s build something together